| Vol. 11.29 – 25 July, 2023 |
| |
|
|
| To increase the selectivity of CD229 CAR T cells for multiple myeloma cells, scientists used a single amino acid substitution approach of the CAR binding domain to reduce CAR affinity. [Science Translational Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers showed that the cytokine growth/differentiation factor-15 (GDF-15) impaired leukocyte function-associated antigen (LFA)−1 /β2-integrin-mediated adhesion of T cells to activated endothelial cells, which was a pre-requisite of T cell extravasation. [Nature Communications] |
|
|
|
| The authors showed that loss of Tet methylcytosine dioxygenase 2 (TET2) led to increased chromatin accessibility at exhaustion regulators thymocyte selection-associated high mobility group box protein (TOX) and TOX2, plus increased expression of TOX2. [Science Advances] |
|
|
|
| Using the targeted C3 inhibitor CR2-Crry led to a significant decrease in complement deposition and demyelination in both slice cultures and focal intracerebral injection models. [Molecular Therapy] |
|
|
|
| Scientists developed functional in vivo confocal microscopy to investigate immune cell dynamics in the human corneal epithelium and stroma. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Investigators identified two tumor-infiltrating lymphocytes subsets with high expression of CD103 and LAG3, including a CD8+ T cell subset and a B cell subset. [BMC Medicine] |
|
|
|
|
The authors determined the role of neutrophil extracellular traps (NETs) in promoting angiogenesis in gastric cancer. Multiple immunohistochemical staining was used to analyze the spatial distribution of NETs and microvessels in patient tissue samples. [Cell Communication and Signaling] |
| | Investigators evaluated naïve CD4+ T cells polarized into Th2 cells, total CD4+ T cells treated with IL-4 for 72 h, and CD4+ T cells isolated from healthy donors and atopic dermatitis patients. [Inflammation Research] |
|
|
|
| Scientists showed that IFN-γ–activated human dermal lymphatic endothelial cells could robustly reactivate allogeneic human memory CD4+ T cells, but only when TGF-β signaling was inhibited. [Journal of Immunology] |
|
|
|
| Researchers evaluated changes in T cell subtypes upon co-culture of patient-derived pancreatic ductal adenocarcinoma organoids and matched peripheral blood mononuclear cells. [Journal of Cancer Research and Clinical Oncology] |
|
|
|
|
| The authors summarize the major findings that led to the discovery of RORγt+ antigen-presenting cells and their associated functions, discuss discordance in recent reports, and identify gaps in knowledge in this burgeoning field. [Nature Reviews Immunology] |
|
|
|
| Investigators summarize recent advances in biomaterials for in situ cell therapy including T cells, macrophages, dendritic cells, and stem cells reprogramming leveraging lipid nanoparticles, polymers, inorganic materials, and other biomaterials. [BMEMat] |
|
|
|
|
| Replay and The University of Texas MD Anderson Cancer Center announced that the US FDA has issued a ‘safe to proceed’ for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, a first-in-class engineered TCR-NK cell therapy for relapsed or refractory multiple myeloma. [Replay Bio] |
|
|
|
|
| September 12 – 14, 2023 Munich, Germany |
|
|
|
|
|
| The University Hospital Essen – Essen, Germany |
|
|
|
| City of Hope – Duarte, California, United States |
|
|
|
| ShanghaiTech University – Shanghai, China |
|
|
|
| Centre for Oncology and Immunology – Hong Kong, Hong Kong |
|
|
|
| The Hospital of the University of Munich – Munich, Germany |
|
|
|
|